Association of the Kobner phenomenon with disease activity and therapeuticresponsiveness in vitiligo vulgaris

Objective: To investigate the association between the experimentally induce d Kobner phenomenon (KP-e) and the Kobner phenomenon by history (KP-h), dis ease activity, and therapeutic responsiveness in vitiligo vulgaris. Design: Cohort study. Setting: An outpatient clinic. Patients: Sixty-one consecutive patients with vitiligo vulgaris. Intervention: Three months after a standardized epidermodermal injury was i nduced, the KP-e was evaluated. For 1 year, UV-B (311 nm) therapy or topica l fluticasone propionate plus UV-A therapy was given, depending on the seve rity of depigmentation. Main Outcome Measures: The presence or absence of the KP-e and the KP-h dis ease activity as scored on a 6-point scale from -1 to +4 (vitiligo disease activity [VIDA] score) and therapy-induced repigmentation grade. Results: Nineteen (31%) of the patients had a positive KP-h, whereas 37(61% ) showed a positive KP-e (P<.001). The VIDA score did not always predict a positive KP-e, although patients with a positive KP-e had a higher mean VID A score (VIDA score of 1.6) than did patients with a negative KP-e (VIDA sc ore of 0.5) (P<.001). The responsiveness to W-B (311 nm) therapy among KP-e -positive or KP-e-negative patients was not significantly different (P = .6 6) However, KP-e-positive patients who were treated with fluticasone propio nate plus UV-A showed a better response than did KP-e-negative patients (P = .01). Among patients responding to both therapies, VIDA scores were signi ficantly decreased (P<.001) compared with VIDA scores before therapy. Conclusion: The KP-e may function well as a clinical factor to assess prese nt disease activity and may also predict the responsiveness to fluticasone propionate plus W-A therapy but not to UV-B (311 nm) therapy.